Omran Abul-Khoudoud, MD
Vascular Surgery · Ashland, KYNPI 1083664254
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,327 of the $4,132 with a category attached, or 80.5%. It is spread thinly across 27 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,594, 3.5 times the $459 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in KY, where the typical reported total is $9,151.
Across 110 payments — averaging $37.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$990
- Stryker$941
- Endologix LLC$383
- Johnson & Johnson$338
- Pfizer$194
- Angiodynamics, Inc.$193
- plus $1K from 21 others
Across 14 payments — averaging $1090.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merit Medical Systems Inc$9K
- Boston Scientific$7K
What the payments were for
- Travel & lodging$80519%
- Food & beverage$3,32781%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 14 | $990 |
| Stryker | 7 | $941 |
| Endologix LLC | 1 | $383 |
| Johnson & Johnson(2 entities) | 22 | $338 |
| Pfizer | 13 | $194 |
| Angiodynamics, Inc. | 5 | $193 |
| Shockwave Medical, Inc | 5 | $185 |
| Silk Road Medical, Inc. | 3 | $158 |
| Cvrx, Inc. | 4 | $102 |
| Inari Medical, Inc. | 5 | $92 |
| Tactile Systems Technology Inc | 3 | $73 |
| Cardiovascular Systems Inc. | 4 | $67 |
| Philips North America LLC | 2 | $64 |
| E.r. Squibb & Sons, L.L.C. | 4 | $48 |
| Cook Medical LLC | 3 | $41 |
| Abiomed | 1 | $35 |
| Boston Scientific | 2 | $34 |
| Surmodics, Inc. | 2 | $31 |
| Pulmonx Corporation | 1 | $28 |
| Novartis | 2 | $26 |
| Smith+Nephew | 1 | $20 |
| Cardiva Medical, Inc. | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Teleflex LLC | 1 | $15 |
| Terumo Medical Corporation | 1 | $15 |
| Kerecis Limited | 1 | $14 |
| Avinger Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$805
- FLOWTRIEVER CATHETER, S$805
- Torus Stent Graft System$383
- ENDOCROSS Device$383
- Conformable TAG Thoracic Endoprosthesis$274
- ENROUTE Transcarotid Neuroprotection System$236
- GORE TAG Thoracic Branch Endoprosthesis$210
- EXCLUDER Iliac Branch Endoprosthesis$143
- C3 Delivery System$143
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$118
- ENROUTE Transcarotid Stent$118
- Nanoknife$117
- GORE VIABAHN VBX Balloon Expandable Endo$103
How this compares
$4,132 in reported general payments places this provider in the 25th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $11,181 |
| Warfarin Sodium | 38 | $369 |
| Cilostazol | 18 | $278 |
| ClopidogrelClopidogrel Bisulfate | 39 | $262 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $194 | $11,18115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Ashland
- Loay AljaberiAshland$14K
- David DockrayAshland$5K
- Amit DwivediLouisville$406K
- Igor VoskresenskyLexington$99K
- Nick AbediLexington$95K
- Abindra SigdelLouisville$84K
- Samuel TyagiLexington$70K
- Ferenc NagyLouisville$47K
- Gregory SchmiederLouisville$44K
- Donald BrownSomerset$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.